Skip to main content

The bid comes a week after the U.S. Supreme Court upheld subsidies for individuals under President Barack Obama’s signature healthcare law, keeping a large chunk of patients intact under the Medicare and Medicaid programsAndrei Tchernov/Getty Images/iStockphoto

PointClickCare, a Canadian health-care software provider, filed for an initial public offering in the U.S. and plans to do the same in Canada.

The Mississauga, Ontario-based company plans to list on the Nasdaq Stock Market under the stock symbol PCLK, and intends to go public on the Toronto Stock Exchange as PCC, according to the prospectus and a statement filed Thursday.

PointClickCare is one of a wave of Canadian tech companies beginning to tap public markets. E-commerce software maker Shopify Inc. has increased about 60 per cent in U.S. trading since its listing in May. Hootsuite Media Inc. has said it could go public by the end of 2016 and Vision Critical Communications Inc. is weighing the sale of part of its business ahead of a possible IPO early next year, according to people familiar with the process.

PointClickCare's IPO is being arranged by JPMorgan Chase & Co., Goldman Sachs Group, Royal Bank of Canada, William Blair & Co. and Canaccord Genuity Group Inc.

The company plans to use the proceeds for working capital and general proceeds, to repay debt and cover a special dividend to shareholders of about $17.5-million before the close of the offering.

Report an error

Tickers mentioned in this story

Study and track financial data on any traded entity: click to open the full quote page. Data updated as of 18/03/24 3:49pm EDT.

SymbolName% changeLast
CF-T
Canaccord Genuity Group Inc
0%8.35
GS-N
Goldman Sachs Group
-0.73%384.37
JPM-N
JP Morgan Chase & Company
+1.24%192.66
M-N
Macy's Inc
+0.24%21.24
PM-N
Philip Morris International Inc
+1.12%95.33
RY-N
Royal Bank of Canada
-0.07%99.27
RY-T
Royal Bank of Canada
-0.22%134.34
SHOP-N
Shopify Inc
+0.48%77.52
SHOP-T
Shopify Inc
+0.43%104.93
Y-T
Yellow Pages Ltd
0%10

Interact with The Globe